
|Articles|November 23, 2011
EpiCor Receives NDI Approval
While Embria says its ingredient is protected under FDA’s grandfather clause, company president Paul Faganel said that the move provides additional assurance for its customers and manufacturing partners.
Advertisement
EpiCor, the immune-balancing ingredient from Embria Health Sciences (Ankeny, IA), has received New Dietary Ingredient (NDI) notification from the FDA, the company reports.
While Embria says its ingredient is protected under FDA’s grandfather clause, company president Paul Faganel said that the move provides additional assurance for its customers and manufacturing partners.
Newsletter
From ingredient science to consumer trends, get the intel you need to stay competitive in the nutrition space—subscribe now to Nutritional Outlook.
Advertisement
Advertisement
Advertisement
Trending on Nutritional Outlook - Supplement, Food & Beverage Manufacturing Trends
1
The paradox in supplement research
2
Filling a research gap: Omega-3 biomarkers and early-onset dementia
3
The role of B6, B12, and folate in one-carbon metabolism and SAMe synthesis
4
How GC Rieber VivoMega is adapting fish and algal omega-3 production to a changing market
5




